IFNB1 and infection: The importance of administration timing has been highlighted by a recent report in which delayed IFN-β administration in MERS-CoV-infected mice exacerbated a pro-inflammatory state and increased infiltration of activated monocytes, macrophages and neutrophils in the lung, ultimately resulting in a worse outcome (e.g., fatal pneumonia), compared to mice treated within one day after infection [91].